Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Fulgent Genetics Inc before investing.

In this article, we go over a few key elements for understanding Fulgent Genetics Inc’s stock price such as:

• Fulgent Genetics Inc’s current stock price and volume
• Why Fulgent Genetics Inc’s stock price changed recently
• Upgrades and downgrades for FLGT from analysts
• FLGT’s stock price momentum as measured by its relative strength

About Fulgent Genetics Inc (FLGT)

Before we jump into Fulgent Genetics Inc’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

Fulgent Genetics, Inc. is a technology-based genetic company with a laboratory services business and a therapeutic development business. The Company’s laboratory services business includes technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a range of cancers using a nanoencapsulation and targeted therapy platform designed to improve the therapeutic window and pharmacokinetic profile (PK) profile of new and existing cancer drugs. Its technology platform for its laboratory services business includes gene probes, data suppression and comparison algorithms, learning software, and laboratory information management systems. The platform provides a test menu, the ability to rapidly develop and launch new tests and customizable test offerings. The Company also offers next-generation sequencing (NGS) services.

Want to learn more about Fulgent Genetics Inc’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Fulgent Genetics Inc.

Fulgent Genetics Inc’s Stock Price as of Market Close

As of July 18, 2024, 4:00 PM, CST, Fulgent Genetics Inc’s stock price was $22.02.

Fulgent Genetics Inc is down 5.53% from its previous closing price of $23.31.

During the last market session, Fulgent Genetics Inc’s stock traded between $21.67 and $23.73. Currently, there are 29.77 million shares of Fulgent Genetics Inc stock available for purchase.

Unfortunately, Fulgent Genetics Inc’s P/E ratio is not significant enough to use for stock price evaluation. We recommend investors evaluate other financial metrics to understand its overall valuation.

Fulgent Genetics Inc Stock Price History

Fulgent Genetics Inc’s (FLGT) price is currently up 12.23% so far this month.

During the month of July, Fulgent Genetics Inc’s stock price has reached a high of $23.73 and a low of $19.52.

Over the last year, Fulgent Genetics Inc has hit prices as high as $44.09 and as low as $18.91. Year to date, Fulgent Genetics Inc’s stock is down 26.06%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Fulgent Genetics Inc Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of July 17, 2024, there was 1 analyst who downgraded Fulgent Genetics Inc’s stock and 1 analyst who upgraded over the last month.

Additionally, you'll want to evaluate Fulgent Genetics Inc’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Fulgent Genetics Inc’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Fulgent Genetics Inc’s current valuation based on AAII’s Value Grade is a C, which means it is considered to be Average.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Fulgent Genetics Inc (FLGT) by visiting AAII Stock Evaluator.

Relative Price Strength of Fulgent Genetics Inc

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of July 17, 2024, Fulgent Genetics Inc has a weighted four-quarter relative price strength of -11.37%, which translates to a Momentum Score of 28 and is considered to be Weak.

Want to learn more about how Fulgent Genetics Inc is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Fulgent Genetics Inc Stock Price: Bottom Line

As of July 18, 2024, Fulgent Genetics Inc’s stock price is $22.02, which is down 5.53% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Fulgent Genetics Inc stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.